Literature DB >> 16337422

The relationship between histopathological features of progressive supranuclear palsy and disease duration.

Keith A Josephs1, Jayawant N Mandrekar, Dennis W Dickson.   

Abstract

Progressive supranuclear palsy (PSP) is a distinct clinicopathological entity characterized by neurofibrillary tangles, tufted astrocytes, threads and oligodendroglial coiled bodies. These four lesions are distributed in varying densities throughout subcortical and brainstem structures. There is no data regarding the relationship of disease duration to lesion burden severity in PSP. We report the results of analysis of semiquantitative data collected as part of the diagnostic evaluation on 97 cases of 'pure' PSP, submitted to the Society of PSP Brain Bank. Surprisingly, the data suggests that in PSP as duration of illness increases there is a decrease in oligodendroglial tau burden.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337422     DOI: 10.1016/j.parkreldis.2005.08.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

1.  Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP?

Authors:  Virgilio Gerald H Evidente; Charles H Adler; Marwan N Sabbagh; Donald J Connor; Joseph G Hentz; John N Caviness; Lucia I Sue; Thomas G Beach
Journal:  Parkinsonism Relat Disord       Date:  2011-03-21       Impact factor: 4.891

2.  Evolution of oculomotor and clinical findings in autopsy-proven Richardson syndrome.

Authors:  A Hardwick; J C Rucker; M L Cohen; R P Friedland; K Gustaw-Rothenberg; D E Riley; R J Leigh
Journal:  Neurology       Date:  2009-12-15       Impact factor: 9.910

3.  Clinical correlates of white matter tract degeneration in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; Ankit V Master; Ramesh Avula; Kejal Kantarci; Scott D Eggers; Heidi A Edmonson; Clifford R Jack; Keith A Josephs
Journal:  Arch Neurol       Date:  2011-06

4.  MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.

Authors:  Jennifer L Whitwell; Nirubol Tosakulwong; Christopher G Schwarz; Hugo Botha; Matthew L Senjem; Anthony J Spychalla; J Eric Ahlskog; David S Knopman; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Mov Disord       Date:  2018-11-23       Impact factor: 10.338

5.  Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies.

Authors:  Keith A Josephs; Nirubol Tosakulwong; Stephen D Weigand; Marina Buciuc; Val J Lowe; Dennis W Dickson; Jennifer L Whitwell
Journal:  J Nucl Med       Date:  2021-09-23       Impact factor: 11.082

6.  Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.

Authors:  Richard M Tsai; Iryna Lobach; Jee Bang; Jennifer L Whitwell; Matthew L Senjem; Clifford R Jack; Howard Rosen; Bruce Miller; Adam L Boxer
Journal:  Parkinsonism Relat Disord       Date:  2016-04-24       Impact factor: 4.891

7.  Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy.

Authors:  Shinsuke Fujioka; Avi A Algom; Melissa E Murray; Audrey Strongosky; Alexandra I Soto-Ortolaza; Rosa Rademakers; Owen A Ross; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Neurology       Date:  2013-05-01       Impact factor: 9.910

8.  Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review.

Authors:  Emil Ygland; Danielle van Westen; Elisabet Englund; Rosa Rademakers; Zbigniew K Wszolek; Karin Nilsson; Christer Nilsson; Maria Landqvist Waldö; Irina Alafuzoff; Oskar Hansson; Lars Gustafson; Andreas Puschmann
Journal:  Alzheimers Res Ther       Date:  2018-01-09       Impact factor: 6.982

9.  Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions.

Authors:  Xue Wang; Mariet Allen; Özkan İş; Joseph S Reddy; Frederick Q Tutor-New; Monica Castanedes Casey; Minerva M Carrasquillo; Stephanie R Oatman; Yuhao Min; Yan W Asmann; Cory Funk; Thuy Nguyen; Charlotte Cg Ho; Kimberly G Malphrus; Nicholas T Seyfried; Allan I Levey; Steven G Younkin; Melissa E Murray; Dennis W Dickson; Nathan D Price; Todd E Golde; Nilüfer Ertekin-Taner
Journal:  J Clin Invest       Date:  2022-01-18       Impact factor: 19.456

10.  Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain.

Authors:  Gabor G Kovacs; Sharon X Xie; John L Robinson; Edward B Lee; Douglas H Smith; Theresa Schuck; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol Commun       Date:  2018-06-11       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.